secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0001140361-23-046335
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics appoints Alison C. Finger to board as Class I director
---------------------------------------------------------------------

- Alison C. Finger appointed to board effective Sept 28, 2023; term expires at 2026 annual meeting.
- Ms. Finger was Chief Commercial Officer at bluebird bio (Aug 2015-Jan 2021) and held VP roles at BMS.
- Initial grant of options to purchase 98,870 shares of common stock upon joining the board.
- No arrangements or transactions requiring disclosure under Item 404(a) exist.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036123046335/0001140361-23-046335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036123046335/ef20011676_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-046335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer